drugset
drugset / Trial / NCT02607319

Low Molecular Weight Heparin to Improve Pregnancy Outcome in Patients With Recurrent Implantation Failure

NCT02607319 ↗

Phase 4 Completed 165 enrolled American University of Beirut Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

The objective of this study is to determine the effect of Bemiparin, a low molecular weight heparin, on implantation rate in women with unexplained recurrent implantation failure undergoing IVF/ICSI treatment.

Timeline

Start
2015-11
Primary completion
2022-07
Completion
2022-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Bemiparin Other / unclassified 3500 iu Other

Indications

infertility disorder